Approval · Notice of Compliance 16331 · 2014
ASA: Notice of Compliance 16331
Issued November 20, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16331
- Date
- November 20, 2014
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Pletelet aggregation inhibitor
- Canadian reference product
- COATED ASPIRIN DAILY LOW DOS 81 MG (Bayer Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ASA | 02433044 | Marketed |
Medicinal ingredients
- ACETYLSALICYLIC ACID 81 MG per TAB